Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001625297-25-000030
Filing Date
2025-05-01
Accepted
2025-05-01 17:21:34
Documents
70
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q indv-20250331.htm   iXBRL 10-Q 880709
2 EX-31.1 ex311ceosoxcert1q2025.htm EX-31.1 9563
3 EX-31.2 ex312cfosoxcert1q2025.htm EX-31.2 9512
4 EX-32.1 ex321ceosoxcert1q2025.htm EX-32.1 3973
5 EX-32.2 ex322cfosoxcert1q2025.htm EX-32.2 3973
  Complete submission text file 0001625297-25-000030.txt   5540774

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT indv-20250331.xsd EX-101.SCH 32555
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT indv-20250331_cal.xml EX-101.CAL 59278
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT indv-20250331_def.xml EX-101.DEF 134642
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT indv-20250331_lab.xml EX-101.LAB 448852
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT indv-20250331_pre.xml EX-101.PRE 329350
73 EXTRACTED XBRL INSTANCE DOCUMENT indv-20250331_htm.xml XML 835492
Mailing Address 234 BATH ROAD SLOUGH, BERKSHIRE X0 SL1 4EE
Business Address 234 BATH ROAD SLOUGH, BERKSHIRE X0 SL1 4EE 804-379-1090
INDIVIOR PLC (Filer) CIK: 0001625297 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37835 | Film No.: 25904437
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)